DR. FREDERICK KARL SWIGER M.D. NPI 1740283530

NPI Details

DR. Frederick Karl Swiger, M.D. is an anatomic pathology and clinical pathology pathology in Rome, GA with 34 years of experience. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. DR. Frederick Karl Swiger, M.D. NPI is 1740283530. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Graduation Year:1992

The provider's business location address is:

311 W 8TH ST NE
ROME, GA
ZIP 30165-723
Phone: (706) 291-8702
Fax: (706) 291-6514

The NPI 1740283530 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
• Microscopic genetic analysis of tumor, using computer-assisted technology (HCPCS:88361)
• Blood smear interpretation by physician with written report (HCPCS:85060)
• Pathology examination of specimen during surgery, first tissue block (HCPCS:88331)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Protein measurement, serum (HCPCS:84165)
• Measurement of antibody to noninfectious agent (HCPCS:86256)
• Cell examination of specimen, concentration technique (HCPCS:88108)
• Evaluation of fine needle aspirate with interpretation and report (HCPCS:88173)
• Protein measurement, body fluid (HCPCS:84166)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Immunologic analysis technique on serum (HCPCS:86320)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Immunologic analysis technique on body fluid, other fluids with concentration (HCPCS:86335)
• Evaluation of fine needle aspirate (HCPCS:88172)
• Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode (HCPCS:88177)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Pathology examination of specimen during surgery, first tissue block (HCPCS:88331)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Pathology examination of tissue using a microscope, high complexity (HCPCS:88309)
• Pathology examination of specimen during surgery, each additional tissue block (HCPCS:88332)
• Bone marrow, smear interpretation (HCPCS:85097)
• Pap test (HCPCS:88141)

The enumeration date for this NPI number is 5/24/2005 and was last updated on 9/10/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.